HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guido Stoll Selected Research

von Willebrand factor receptor (VWF receptor)

9/2011Ischaemic stroke: a thrombo-inflammatory disease?
10/2010Combating innate inflammation: a new paradigm for acute treatment of stroke?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guido Stoll Research Topics

Disease

50Stroke (Strokes)
06/2022 - 03/2006
26Thrombosis (Thrombus)
10/2021 - 11/2005
24Ischemic Stroke
03/2022 - 05/2007
23Infarction (Infarctions)
05/2022 - 01/2002
19Inflammation (Inflammations)
01/2022 - 01/2002
17Brain Ischemia (Cerebral Ischemia)
01/2016 - 01/2002
15Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2022 - 01/2002
8Hemorrhage
03/2022 - 03/2006
7Neuroinflammatory Diseases
01/2022 - 01/2007
6Reperfusion Injury
06/2022 - 05/2015
6Cerebral Infarction
05/2022 - 11/2003
6Brain Infarction
08/2021 - 04/2008
6Wallerian Degeneration
03/2008 - 01/2002
5Ischemia
11/2019 - 01/2002
4Multiple Sclerosis
01/2019 - 09/2008
4Peripheral Nerve Injuries
07/2012 - 11/2003
4Edema (Dropsy)
04/2011 - 01/2009
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
02/2010 - 01/2007
4Demyelinating Diseases (Demyelinating Disease)
09/2008 - 10/2003
3Brain Edema (Cerebral Edema)
04/2011 - 01/2009
2Hypoxia (Hypoxemia)
06/2022 - 04/2011
2Atrophy
01/2022 - 01/2018
2Cognitive Dysfunction
01/2022 - 01/2018
2Myasthenia Gravis
10/2019 - 07/2002
2Cerebral Hemorrhage
01/2017 - 12/2015
2Myocardial Infarction
07/2012 - 04/2010
2Nerve Degeneration
06/2010 - 03/2005
2Neuralgia (Stump Neuralgia)
03/2010 - 08/2006
2Experimental Autoimmune Neuritis
03/2008 - 01/2006
1Heart Failure
01/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Muscle Weakness
10/2019

Drug/Important Bio-Agent (IBA)

10Contrast MediaIBA
01/2013 - 03/2005
9Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2004
9Glycoproteins (Glycoprotein)IBA
02/2021 - 04/2009
9CytokinesIBA
05/2019 - 01/2002
9Factor XII (Hageman Factor)IBA
01/2019 - 03/2006
8ferric oxide (iron oxide)IBA
01/2011 - 11/2003
7von Willebrand FactorIBA
01/2014 - 04/2009
7gadofluorine MIBA
11/2009 - 03/2005
6GadoliniumIBA
01/2019 - 03/2005
5AntigensIBA
02/2021 - 05/2010
5KininsIBA
11/2012 - 01/2009
5Messenger RNA (mRNA)IBA
01/2007 - 01/2002
4ChemokinesIBA
01/2022 - 08/2006
4CalciumIBA
11/2019 - 07/2008
4LigandsIBA
01/2019 - 04/2009
4Bradykinin Receptors (Bradykinin Receptor)IBA
03/2011 - 05/2008
3EnzymesIBA
06/2022 - 06/2010
3InflammasomesIBA
03/2022 - 01/2021
3Tissue Plasminogen Activator (Alteplase)FDA Link
03/2022 - 10/2018
3Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2011
3Platelet Membrane GlycoproteinsIBA
01/2022 - 12/2015
3Immunoglobulin G (IgG)IBA
03/2021 - 03/2015
3AntibodiesIBA
10/2019 - 06/2013
3Collagen ReceptorsIBA
01/2016 - 10/2010
3triphenyltetrazoliumIBA
12/2015 - 05/2007
3IronIBA
06/2010 - 06/2005
3Interleukin-18 (Interleukin 18)IBA
01/2010 - 01/2002
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2009 - 01/2002
3Interleukin-1beta (Interleukin 1 beta)IBA
01/2006 - 01/2002
2HMGB1 Protein (HMG1)IBA
10/2021 - 08/2021
2adhesion receptorIBA
02/2021 - 04/2009
2Caspase 1 (ICE Protease)IBA
01/2021 - 01/2002
2Glucose (Dextrose)FDA LinkGeneric
11/2019 - 04/2011
2Oxygen (Dioxygen)IBA
11/2019 - 01/2009
2Pharmaceutical PreparationsIBA
11/2019 - 09/2010
2CollagenIBA
04/2019 - 10/2010
2Factor XIIa (Coagulation Factor XIIa)IBA
01/2016 - 01/2016
2LipidsIBA
09/2013 - 07/2006
2CoagulantsIBA
07/2013 - 09/2011
2FluorocarbonsIBA
07/2012 - 01/2011
2von Willebrand factor receptor (VWF receptor)IBA
09/2011 - 10/2010
2Immunoglobulin Fab FragmentsIBA
04/2011 - 05/2007
2Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA
04/2011 - 05/2007
2ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
06/2010 - 06/2005
2FibrinIBA
04/2010 - 03/2006
2Myelin-Oligodendrocyte GlycoproteinIBA
02/2010 - 09/2008
2Interleukin-1 (Interleukin 1)IBA
01/2010 - 01/2002
2Gadolinium DTPA (Magnevist)FDA Link
11/2009 - 03/2008
2Peptide Hydrolases (Proteases)FDA Link
04/2008 - 03/2006
2Coloring Agents (Dyes)IBA
04/2008 - 05/2002
2Rose BengalIBA
04/2008 - 05/2002
2Monoclonal AntibodiesIBA
05/2007 - 01/2006
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2007 - 01/2004
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2006 - 01/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006 - 01/2002
1EndoglinIBA
06/2022
1ImmunosorbentsIBA
06/2022
1pro-brain natriuretic peptide (1-76)IBA
01/2022
1Glial Fibrillary Acidic ProteinIBA
01/2022
1platelet membrane glycoprotein VIIBA
10/2021
1AlbuminsIBA
03/2021
1Therapeutic UsesIBA
02/2021
1Calcium Channels (Calcium Channel)IBA
11/2019
1Cholinergic ReceptorsIBA
10/2019
1Cholinergic Agents (Cholinergics)IBA
10/2019

Therapy/Procedure

12Thrombectomy
05/2022 - 10/2018
6Therapeutics
10/2021 - 06/2010
2Microelectrodes
08/2019 - 05/2019